All but one (16 out of 17) patients of this cohort carried the wild type alleles for TLR4D299G and all for TLR4T399I polymorphisms, making us unable to assess the relationship between TLR4 polymorphisms and response to OM-174, either in terms of biological or clinical response. This evidence concerns the gene TLR4 and ocular melanoma.